← Back to Clinical Trials
Recruiting NCT07008950

NCT07008950 Self-efficacy and Knowledge (SEEK) Trial to Improve Sexual Reproductive Health and Well-being for Syrian Refugee Women and Girls in Lebanon

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07008950
Status Recruiting
Phase
Sponsor American University of Beirut Medical Center
Condition Mental Health Care
Study Type INTERVENTIONAL
Enrollment 485 participants
Start Date 2024-01-01
Primary Completion 2025-05-01

Eligibility & Interventions

Sex Female only
Min Age 15 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
The Self-Efficacy and Knowledge Trial

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 485 participants in total. It began in 2024-01-01 with a primary completion date of 2025-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This community-based randomized controlled trial (RCT) aims to evaluate a low-resource/low-intensity integrated sexual reproductive health (SRH) and wellbeing intervention package. It will be delivered in Primary Healthcare Centres (PHCs) in a rural area in Lebanon to Syrian refugee women and girls aged 15-24.

Eligibility Criteria

Inclusion Criteria: \- The target population of the study are Syrian adolescent girls and young women refugees (age 15-24 years) residing in Beqaa governorate in Lebanon. Participants will be included in the study if they meet the following inclusion criteria: 1. are currently married and between the ages of 15 - 24 years, 2. completed an average stay in Lebanon for a minimum of 6 months, 3. are willing to take part in the study as indicated by them signing an informed consent (for young women 18 years of age or older) or through a legal guardian consent form and written assent for adolescents' girls between 15 and 17, 4. have none of the exclusion criteria listed below upon screening. Exclusion Criteria: Participants will be excluded from the study if they meet any of the following criteria: 1. are currently pregnant and/or lactating, 2. have reported chronic health problems interfering with the ability to follow the intervention protocol, 3. have high levels of anxiety and/or depression as well as suicidal ideations and/or attempts upon screening and/or a current diagnosis of a severe mental illness, or undergoing mental health treatment. \-

Contact & Investigator

Central Contact

Shadi Saleh, PhD, MPH

✉ ss117@aub.edu.lb

📞 +961 3 047 578

Principal Investigator

Shadi Saleh, PhD

PRINCIPAL INVESTIGATOR

Global Health Institute American University of Beirut

Frequently Asked Questions

Who can join the NCT07008950 clinical trial?

This trial is open to female participants only, aged 15 Years or older, up to 15 Years, studying Mental Health Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07008950 currently recruiting?

Yes, NCT07008950 is actively recruiting participants. Contact the research team at ss117@aub.edu.lb for enrollment information.

Where is the NCT07008950 trial being conducted?

This trial is being conducted at Beirut, Lebanon.

Who is sponsoring the NCT07008950 clinical trial?

NCT07008950 is sponsored by American University of Beirut Medical Center. The principal investigator is Shadi Saleh, PhD at Global Health Institute American University of Beirut. The trial plans to enroll 485 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology